Alexion Pharmaceuticals Inc.

NASDAQ:ALXN   12:42:34 PM EDT
180.76
+0.93 (+0.52%)
Regulatory, Mergers / Acquisitions

AstraZeneca Says Continues To Expect Closing of Alexion Deal In Q3 2021

Published: 05/25/2021 07:50 GMT
Alexion Pharmaceuticals Inc. (ALXN) - Astrazeneca, on Cma Review of Alexion Deal, Says Review Commencement Another Step Towards Closing of Proposed Deal, Which Co Continues to Expect in Q3.
Further Company Coverage: Alxn.
Oaznl ((reuters.
Briefs@thomsonreuters.
Com;)).